Società Siegfried Holding AG

SFZN

CH0014284498

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Rating per Siegfried Holding AG

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - Swiss Exchange Altri mercati azionari 17:31:30 26/04/2024			Variaz. 5gg	Var. 1 gen.
876 ^CHF	+0,69%		-1,46%	+1,92%

02/04	Lonza ha trovato il nuovo Ceo, viene da Siegfried	AW
02/04	L'Amministratore delegato di Siegfried si dimette; il responsabile finanziario viene nominato Amministratore delegato ad interim	MT

Siegfried Holding AG è una società di scienze della vita con sede in Svizzera, attiva nella produzione primaria e secondaria di farmaci. L'azienda produce sia sostanze farmacologiche che prodotti farmaceutici. Il portafoglio di sostanze farmaceutiche comprende lo sviluppo e la produzione a contratto di ingredienti farmaceutici attivi (API) e intermedi. Il portafoglio di prodotti farmaceutici comprende licenze e contratti o co-sviluppo e produzione di solidi orali e sterili. I prodotti e le sostanze dell'Azienda sono sviluppati per il trattamento di ipertensione, iperplasia prostatica benigna, depressione, leucemia mieloide cronica, glaucoma, asma, schizofrenia e disturbi bipolari e diabete. L'Azienda gestisce impianti di produzione in Svizzera, Germania, Francia, Malta, Stati Uniti, Cina e Spagna.

Numero di dipendenti: 3 945

CHF in Milioni	2022	Peso	2023	Peso	Delta
Drug Substances 67,6 %	754	61,3 %	860	67,6 %	+14,10%
Drug Products 32,4 %	476	38,7 %	412	32,4 %	-13,51%

CHF in Milioni	2022	Peso	2023	Peso	Delta
Switzerland 100,0 %	1 230	100,0 %	1 271	100,0 %	+3,41%

Dirigenti	Titolo	Età	Da
Wolfgang Wienand CEO	Chief Executive Officer	52	01/08/10
Reto Suter DFI	Director of Finance/CFO	53	01/05/17
Jürgen Roos CTO	Chief Tech/Sci/R&D Officer	56	01/04/19
Christa Brügger PRN	Corporate Officer/Principal	-	01/02/14
Marcel Imwinkelried PRN	Corporate Officer/Principal	57	01/01/21
Irene Wosgien HRO	Human Resources Officer	51	01/01/21
Marianne Späne PRN	Corporate Officer/Principal	61	01/06/04

Amministratori	Titolo	Età	Da
Martin Schmid BRD	Director/Board Member	55	01/01/16
Wolfram Carius BRD	Director/Board Member	63	01/01/14
Andreas Casutt CHM	Chairman	61	01/01/10
Beat Walti BRD	Director/Board Member	55	13/04/22
Isabelle Welton BRD	Director/Board Member	61	01/01/20
Alexandra Brand BRD	Director/Board Member	53	13/04/22
Elodie Carr-Cingari BRD	Director/Board Member	50	20/04/23

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	4 513 000	3 957 148 ( 87,68 %)	223 653 ( 4,956 %)	87,68 %

Nome	Azioni	%	Valorizzazione
Ernst Göhner Stiftung 5,058 %	226 000	5,058 %	231 M CHF
Interogo Foundation 5,017 %	224 167	5,017 %	229 M CHF
SIEGFRIED HOLDING AG 5,009 %	223 811	5,009 %	229 M CHF
BlackRock Fund Advisors 2,991 %	133 645	2,991 %	137 M CHF
Zürcher Kantonalbank (Investment Management) 2,976 %	132 977	2,976 %	136 M CHF
Credit Suisse Asset Management (Schweiz) AG 2,900 %	129 572	2,900 %	132 M CHF
Famiglia Braginsky 2,865 %	128 000	2,865 %	131 M CHF
Delta Lloyd Asset Management NV 0,9167 %	40 958	0,9167 %	42 M CHF
BayernInvest Kapitalverwaltungsgesellschaft mbH 0,9156 %	40 911	0,9156 %	42 M CHF
LBBW Asset Management Investmentgesellschaft mbH 0,8996 %	40 195	0,8996 %	41 M CHF

Nome	Azioni	%	Valorizzazione
SIEGFRIED HOLDING AG 5.01%	223 811	5.01%	228 855 259 $

Siegfried Holding AG

Untere Brühlstrasse 4

4800, Zofingen

+41 62 746 1111

http://www.siegfried.ch

Nome	Categoria e settore
Siegfried AG Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The private company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG.	Chemicals: Agricultural
Siegfried (USA), Inc. Siegfried (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried (USA), Inc. is a private company that manufactures and supplies pharmaceutical products. The company is based in Pennsville, NJ.	Pharmaceuticals: Major
Siegfried Hameln GmbH Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany.	Pharmaceuticals: Major
BASF PharmaChemikalien GmbH & COKG BASF PharmaChemikalien GmbH & COKG Chemicals: Major DiversifiedProcess Industries Part of Siegfried Holding AG, BASF PharmaChemikalien GmbH & COKG is a German company that offers innovative products to meet the current and future needs of businesses and society. The private company is based in Ludwigshafen, Germany. The company's product range can be found through industry research or their product search. The company's goal is to grow profitably and create value for society by creating chemistry for a sustainable future.	Chemicals: Major Diversified
Siegfried Finance AG
BASF Pharma (St. Vulbas) SAS BASF Pharma (St. Vulbas) SAS Chemicals: SpecialtyProcess Industries BASF Pharma (St. Vulbas) SAS manufactures basic organic chemicals. The company is headquartered in Saint-Vulbas, France.	Chemicals: Specialty
Siegfried St. Vulbas SASU Siegfried St. Vulbas SASU Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried St. Vulbas SASU is a pharmaceutical and French chemical company that offers integrated partnership benefits to its customers. The private company is based in Saint-Vulbas, France. The company combines a long tradition of pharmaceutical and chemistry with the innovative approach of an "integrated supplier" to provide more synergy, expertise, and value. The company was founded in 1992. Philippe Moy has been the CEO of the company since 2020.	Pharmaceuticals: Major
Siegfried PharmaChemikalien Minden GmbH Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The private company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried.	Chemicals: Specialty
Siegfried Evionnaz SA
Siegfried Pharma AG
Siegfried Malta Ltd.
Siegfried Hong Kong Ltd.
Siegfried Barbera SL
Siegfried el Masnou SA

Rating Trading

Rating Investimento

ESG Refinitiv

B+

Altri rating

Vendita

Buy

Raccomandazione media

Buy

Numero di analisti

Ultimo prezzo di chiusura

876 CHF

Prezzo obiettivo medio

1.016 CHF

Differenza / Target Medio

+15,97%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
SIEGFRIED HOLDING AG	+1,92%	4,11 Mrd
ELI LILLY AND COMPANY	+25,83%	661 Mrd
NOVO NORDISK A/S	+27,00%	566 Mrd
JOHNSON & JOHNSON	-6,76%	352 Mrd
MERCK & CO., INC.	+20,34%	332 Mrd
ABBVIE INC.	+3,00%	283 Mrd
ASTRAZENECA PLC	+13,09%	231 Mrd
NOVARTIS AG	+5,46%	200 Mrd
ROCHE HOLDING AG	-9,61%	195 Mrd
AMGEN INC.	-6,26%	145 Mrd

Prodotti farmaceutici - Altri